South Wales, March 16 -- United Kingdom Intellectual Property Office (UKIPO) has registered trademark "RE-AIM" on Feb. 20. The details about the trademark application no. UK00004343277 published in the journal no. 2026/010 (March 6).
With Kilburn & Strode LLP as representative, Re-Aim Therapeutics Ltd filed the trademark application for the below mentioned good(s)/service(s).
Class 5 : Pharmaceuticals; therapeutics; pharmaceuticals and therapeutics for the treatment of autoimmune diseases; pharmaceuticals and therapeutics for the treatment of inflammatory diseases and conditions; pharmaceuticals and therapeutics for the treatment of irritable bowel disease, metabolic disorders, psoriasis, psoriatic arthritis, hidradenitis suppurativa and ankylosing spondylitis.
The original document can be viewed at: http://www.ipo.gov.uk/cgi-bin/redirect.cgi?type=tmj&link=6¶m1=UK00004343277
Disclaimer: Curated by HT Syndication.
